Fundamental Valuation Report Conn’s(CONN:NAS) Consumer Cyclical:Specialty Retail This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$21.33 (USD) 04/01/2021 Weighted Valuation$21.00 (USD) Overall RatingFairly valued to slightly Overvalued by 1.5% Valuation Models …
Conn’s (CONN:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report HealthEquity(HQY:NAS) Healthcare:Health Information Services This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$68.11 (USD) 04/01/2021 Weighted Valuation$84.67 (USD) Overall RatingUndervalued by 24.3% Valuation Models Comparables: $100.21 (USD) Multiples: $95.66 …
HealthEquity (HQY:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Phreesia(PHR:NYS) Healthcare:Health Information Services This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$55.13 (USD) 04/01/2021 Weighted Valuation$52.65 (USD) Overall RatingFairly valued to slightly Overvalued by 4.5% Valuation Models …
Phreesia (PHR:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Dave & Buster’s Enter(PLAY:NAS) Consumer Cyclical:Restaurants This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$45.31 (USD) 04/01/2021 Weighted Valuation$26.50 (USD) Overall RatingOvervalued by 41.5% Valuation Models Comparables: $25.28 …
Dave & Buster’s Enter (PLAY:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Splunk(SPLK:NAS) Technology:Software – Infrastructure This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$138.27 (USD) 04/01/2021 Weighted Valuation$123.96 (USD) Overall RatingOvervalued by 10.3% Valuation Models Adjusted Book Value: $117.91 …
Splunk (SPLK:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Verint Systems(VRNT:NAS) Technology:Software – Infrastructure This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$45.50 (USD) 04/01/2021 Weighted Valuation$49.62 (USD) Overall RatingUndervalued by 9.1% Valuation Models Multiples: $49.62 (USD) …
Verint Systems (VRNT:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Zuora(ZUO:NYS) Technology:Software – Infrastructure This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$14.99 (USD) 04/01/2021 Weighted Valuation$14.41 (USD) Overall RatingFairly valued to slightly Overvalued by 3.8% Valuation Models …
Zuora (ZUO:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Snowflake(SNOW:NYS) Technology:Software – Application This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$236.79 (USD) 04/01/2021 Weighted Valuation$292.00 (USD) Overall RatingUndervalued by 23.3% Valuation Models Comparables: $329.78 (USD) Valuation …
Snowflake (SNOW:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report PROG Holdings(PRG:NYS) Industrials:Rental & Leasing Services This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$45.40 (USD) 04/01/2021 Weighted Valuation$50.11 (USD) Overall RatingUndervalued by 10.4% Valuation Models Discounted …
PROG Holdings (PRG:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Recro Pharma(REPH:NAS) Healthcare:Drug Manufacturers – Specialty & Generic This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$2.99 (USD) 04/01/2021 Weighted Valuation$3.62 (USD) Overall RatingUndervalued by 21.0% Valuation …
Recro Pharma (REPH:NAS) Fundamental Valuation Report Read more »
Read More